PMC:7095437 / 521-856 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"15","span":{"begin":42,"end":50},"obj":"Species"},{"id":"17","span":{"begin":264,"end":299},"obj":"Disease"}],"attributes":[{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"Tax:9606"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"MESH:D008171"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nd February 4, 2020, in Chongqing, China. Patients were assigned to the early-stage group (onset of symptoms within 4 days) or progressive-stage group (onset of symptoms within 4–7 days) for analysis. CT characteristics and the distribution, size, and CT score of pulmonary parenchymal abnormalities were assessed.\n\nResults\nIn our stud"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":84,"end":89},"obj":"Chemical"},{"id":"T3","span":{"begin":145,"end":150},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"nd February 4, 2020, in Chongqing, China. Patients were assigned to the early-stage group (onset of symptoms within 4 days) or progressive-stage group (onset of symptoms within 4–7 days) for analysis. CT characteristics and the distribution, size, and CT score of pulmonary parenchymal abnormalities were assessed.\n\nResults\nIn our stud"}

{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":42,"end":200},"obj":"Sentence"},{"id":"T8","span":{"begin":201,"end":314},"obj":"Sentence"},{"id":"T9","span":{"begin":316,"end":323},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nd February 4, 2020, in Chongqing, China. Patients were assigned to the early-stage group (onset of symptoms within 4 days) or progressive-stage group (onset of symptoms within 4–7 days) for analysis. CT characteristics and the distribution, size, and CT score of pulmonary parenchymal abnormalities were assessed.\n\nResults\nIn our stud"}